Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Vaccine|April 18, 2017
The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccinationAllison Dauner, Pankaj Agrawal, Jose Salvatico, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2024
A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay SystemRobert H Pullen, Emily Sassano, Pankaj Agrawal, et al.
Health Services Insights|August 3, 2023
Enablers and Barriers to the Scaling Up of Pneumococcal Conjugate Vaccine in India During the COVID-19 Pandemic: A Qualitative StudyRhythm Hora, Arindam Ray, Rashmi Mehra, et al.
Annals of Pediatric Endocrinology & Metabolism|May 20, 2022
Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarctionPankaj Agrawal, Sally Newbold, Ayisha Al Busaidi, et al.
Journal of Cell Science|March 26, 2013
Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitroSonali Sonnylal, Shiwen Xu, Helen Jones, et al.
3D Printing and Additive Manufacturing|October 3, 2024
Recycling of Acrylonitrile Butadiene Styrene from Electronic Waste for the Production of Eco-Friendly Filaments for 3D PrintingRafaela de Oliveira, Milena Heloísa Araújo Silva, Pankaj Agrawal, et al.
Plos One|June 7, 2018
Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune modelErnesto Luna, Pankaj Agrawal, Riyaz Mehta, et al.
International Journal of Molecular Sciences|August 26, 2022
Tailoring Nylon 6/Acrylonitrile-Butadiene-Styrene Nanocomposites for Application against Electromagnetic Interference: Evaluation of the Mechanical, Thermal and Electrical Behavior, and the Electromagnetic Shielding EfficiencyCarlos Bruno Barreto Luna, Emanuel Pereira do Nascimento, Danilo Diniz Siqueira, et al.
NPJ Vaccines|December 20, 2024
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidateErnesto Luna, Sophie Ruiz, Marie Garinot, et al.
Oncoimmunology|September 6, 2021
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatmentHélène Bonnevaux, Stephane Guerif, Jana Albrecht, et al.
Pageof 4